Wednesday, October 12, 2022
8.30 Authorities’ auspices
2. Oocyte storage for Fertility Preservation
Chairs: S. Schettini, A.P. Ferraretti
9.00 Oocyte cryopreservation in adolescents and young adults with cancer
E. Porcu
9.20 Efficiency and safety of ovarian stimulation protocols for oocyte vitrification and cancer outcome
C. Alviggi
9.40 Oocyte storage in BRCA mutation carriers
A. Revelli
10.00 Oocyte storage in Turner Syndrome
M. De Vos
10.20 Oocyte cryopreservation for age-related fertility decline and in young POI patients
A. Cobo
10.40 Discussion
11.00 Break
Chairs: E. Porcu, L. Cipriani
11.20 Oncological management of fertility preservation
F. Peccatori
11.40 Oocyte or ovarian tissue transplantation in cancer patients’ fertility preservation?
D. Meirow
12.00 Oocyte storage and GnRH analogs for optimal management for fertility preservation in cancer
P. Anserini
12.20 Management of fertility preservation with Public Health Assistance
M.C. Fasolino
12.40 Elective egg freezing
P. Patrizio
13.00 Ethical and Legal Aspects of elective oocyte cryopreservation
S. Canestrari
13.20 Discussion
13.40 Lunch
3. Oocyte storage in IVF
Chairs: G. D’Amato, M. Costa
14.40 Routine management of supernumerary oocyte cryopreservation in IVF
E. Porcu
15.00 Oocytes’ storage results from the Italian ART Registry
G. Scaravelli
15.20 Cumulative pregnancy rate with oocyte vitrification
F.M. Ubaldi
15.40 Frozen oocytes versus frozen embryos
A. Borini
16.00 Is PGT recommended after oocyte cryopreservation?
L. Gianaroli
16.20 Obstetric and perinatal outcome after conception with cryopreserved oocytes
P. Levi Setti
16.40 Oocyte cryopreservation in oocyte donation program
N. Noyes
17.00 Discussion
17.20 Break
4. Oocyte storage to save non human species
Chairs: C. Galli, P. Loi
17.40 Domestic animals
S. Ledda
18.10 Wild animals
T. Hildebrandt
18.40 Discussion
19.00 Closing Remarks